TLR7 and Autoimmunity: For instance, a novel selective Toll-like receptor 7/8 inhibitor, known as M5049, has shown potential in treating autoimmunity by blocking multiple TLR7/8 RNA ligands with significant efficacy in murine lupus models [65].